
    
      This study is a prospective, single arm, multi-center, in-clinic study.. There will be two
      consecutive phases of the study:

      A total of up to 260 subjects (2-18 years old) will be enrolled at up to 15 investigational
      centers

      Subjects will come for clinic visit for YSI reference glucose testing and for Enlite Sensor™
      and Enlite 3 Sensor™ testing. SMBG (Self-Monitoring of Blood Glucose) reference measurement
      is for subjects 2-6 years of age and cannot tolerate YSI.

      Study has a run-in period and a study period with a total of 10 visits
    
  